Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
Sally M. Hunter(Peter MacCallum Cancer Centre), Ian Campbell(The University of Sydney), Prue E. Allan(Epworth Hospital), Anna DeFazio(The University of Sydney), David D.L. Bowtell(The University of Melbourne), Michael S. Anglesio(University of British Columbia), Georgina L. Ryland(The University of Sydney), Simone M. Rowley(Victorian Clinical Genetics Services), Yoke-Eng Chiew(The University of Sydney), Maria Doyle(Peter MacCallum Cancer Centre), David G. Huntsman(BC Cancer Agency), Raghwa Sharma(Royal Prince Alfred Hospital), Jason Li(Queen's University), Andrew N. Stephens(Hudson Institute of Medical Research), Phillip Moss(Queen Elizabeth II Health Sciences Centre), C. Blake Gilks(Fox Chase Cancer Center), Kylie L. Gorringe(The University of Melbourne)
Cited by 201
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
|New England Journal of Medicine|2010|1.7k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k